• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by The Bancorp Inc

    5/15/25 11:43:55 AM ET
    $TBBK
    Major Banks
    Finance
    Get the next $TBBK alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    The Bancorp, Inc.

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)


    05969A105

    (CUSIP Number)


    03/31/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    05969A105


    1Names of Reporting Persons

    American Century Investment Management, Inc.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    2,193,691.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    2,628,832.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    2,628,832.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.5 %
    12Type of Reporting Person (See Instructions)

    IA


    SCHEDULE 13G

    CUSIP No.
    05969A105


    1Names of Reporting Persons

    American Century Companies, Inc.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    2,193,691.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    2,628,832.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    2,628,832.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.5 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    CUSIP No.
    05969A105


    1Names of Reporting Persons

    Stowers Institute for Medical Research
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    2,193,691.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    2,628,832.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    2,628,832.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.5 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    The Bancorp, Inc.
    (b)Address of issuer's principal executive offices:

    409 Silverside Road, Wilmington, DE, 19809
    Item 2. 
    (a)Name of person filing:

    American Century Investment Management, Inc. American Century Companies, Inc. Stowers Institute for Medical Research
    (b)Address or principal business office or, if none, residence:

    4500 Main Street 9th Floor Kansas City, Missouri 64111
    (c)Citizenship:

    Delaware
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP No.:

    05969A105
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    See the response(s) to Item 9 on the attached cover page(s).
    (b)Percent of class:

    See the response(s) to Item 11 on the attached cover page(s).
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    See the response(s) to Item 5 on the attached cover page(s).

     (ii) Shared power to vote or to direct the vote:

    See the response(s) to Item 6 on the attached cover page(s).

     (iii) Sole power to dispose or to direct the disposition of:

    See the response(s) to Item 7 on the attached cover page(s).

     (iv) Shared power to dispose or to direct the disposition of:

    See the response(s) to Item 8 on the attached cover page(s).

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    Various persons, including the investment companies and separate institutional investor accounts that American Century Investment Management, Inc. ("ACIM") serves as investment adviser, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities that are the subject of this schedule. Except as may be otherwise indicated if this is a joint filing, not more than 5% of the class of securities that is the subject of this schedule is owned by any one client advised by ACIM.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    This Item identifies each subsidiary of American Century Companies, Inc. ("ACC"), which is controlled by the Stowers Institute for Medical Research, that is a beneficial owner of securities that are subject of this schedule (the "Subject Securities"). American Century Investment Management, Inc. ("ACIM") is a wholly-owned subsidiary of ACC and an investment adviser registered under Section 203 of the Investment Advisers Act of 1940.
    Item 8.Identification and Classification of Members of the Group.
     
    If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(K), so indicate under Item 3(k) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.


    Not applicable
    Item 9.Notice of Dissolution of Group.
     
    Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5.


    Not applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    American Century Investment Management, Inc.
     
    Signature:American Century Investment Management, Inc.
    Name/Title:/s/ John Pak / Senior Vice President
    Date:05/15/2025
     
    American Century Companies, Inc.
     
    Signature:American Century Companies, Inc.
    Name/Title:/s/ John Pak / Senior Vice President
    Date:05/15/2025
     
    Stowers Institute for Medical Research
     
    Signature:Stowers Institute for Medical Research
    Name/Title:/s/ Joselyn Verschelden / Authorized Signer
    Date:05/15/2025
    Exhibit Information

    EXHIBIT Each of the undersigned hereby agrees and consents to the execution and joint filing on its behalf by American Century Investment Management, Inc. of this Schedule 13G respecting the beneficial ownership of the securities which are the subject of this schedule. Dated this 15th day of May, 2025. AMERICAN CENTURY INVESTMENT MANAGEMENT, INC. ("ACIM") AMERICAN CENTURY COMPANIES, INC. ("ACC") By: __/s/ John Pak____________ John Pak Senior Vice President, ACIM and ACC STOWERS INSTITUTE FOR MEDICAL RESEARCH, solely in its capacity as control entity of ACC By: __/s/ Joselyn Verschelden_____ Joselyn Verschelden Authorized Signer

    Get the next $TBBK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TBBK

    DatePrice TargetRatingAnalyst
    1/30/2023$38.00Outperform
    Raymond James
    1/12/2022$40.00Outperform
    Keefe Bruyette
    11/1/2021$30.00 → $38.00Strong Buy
    Raymond James
    More analyst ratings

    $TBBK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • The Bancorp, Inc. Reports First Quarter Financial Results

      The Bancorp, Inc. ("The Bancorp" or the "Company" or "we" or "our") (NASDAQ:TBBK), a financial holding company, today reported its financial results for the first quarter of 2025. Highlights The Bancorp reported net income of $57.2 million, or $1.19 per diluted share ("EPS"), for the quarter ended March 31, 2025, compared to net income of $56.4 million, or $1.06 per diluted share, for the quarter ended March 31, 2024, or an EPS increase of 12%. While net income increased 1% between these periods, outstanding shares were reduced as a result of increased repurchases that occurred during 2024. Return on assets and return on equity for the quarter ended March 31, 2025, amounted to 2.5% an

      4/24/25 4:50:00 PM ET
      $TBBK
      Major Banks
      Finance
    • The Bancorp, Inc. Sets First Quarter 2025 Financial Results Release Date and Conference Call

      The Bancorp, Inc. ("Bancorp") (NASDAQ:TBBK) today announced that it will release its first quarter 2025 financial results after market hours on Thursday, April 24, 2025, and invites investors and other interested parties to listen to its earnings results conference call on Friday, April 25, 2025, at 8:00 a.m. Eastern time. All interested parties can access the live conference call webcast by visiting The Bancorp site at www.thebancorp.com and clicking on the webcast link located on the home page or by dialing 1.800.549.8228 (conference ID 80395). For those who are not available to listen to the live broadcast, the replay will be available following the live call via webcast on Bancorp's we

      4/11/25 8:30:00 AM ET
      $TBBK
      Major Banks
      Finance
    • The Bancorp, Inc. Receives Expected Nasdaq Notice Regarding Delayed Annual Report

      No Immediate Effect on the Company's Securities Listed on Nasdaq The Bancorp, Inc. ("The Bancorp" or the "Company" or "we" or "our") (NASDAQ:TBBK), a financial holding company, today announced that on March 27, 2025, it received an expected notice (the "Notice") from the Listing Qualifications Department of the Nasdaq Global Select Market ("Nasdaq") indicating that, as a result of the Company's delay in filing its Annual Report on Form 10-K for the period ended December 31, 2024 (the "Annual Report") with the Securities and Exchange Commission (the "SEC") the Company is not in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule").

      3/27/25 4:05:00 PM ET
      $TBBK
      Major Banks
      Finance

    $TBBK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Raymond James initiated coverage on The Bancorp with a new price target

      Raymond James initiated coverage of The Bancorp with a rating of Outperform and set a new price target of $38.00

      1/30/23 8:51:21 AM ET
      $TBBK
      Major Banks
      Finance
    • Keefe Bruyette initiated coverage on The Bancorp with a new price target

      Keefe Bruyette initiated coverage of The Bancorp with a rating of Outperform and set a new price target of $40.00

      1/12/22 7:11:25 AM ET
      $TBBK
      Major Banks
      Finance
    • Raymond James reiterated coverage on The Bancorp with a new price target

      Raymond James reiterated coverage of The Bancorp with a rating of Strong Buy and set a new price target of $38.00 from $30.00 previously

      11/1/21 5:24:07 AM ET
      $TBBK
      Major Banks
      Finance

    $TBBK
    Leadership Updates

    Live Leadership Updates

    See more
    • The Bancorp Appoints Dwayne Allen to Its Board of Directors

      The Bancorp, Inc. (NASDAQ:TBBK), through its subsidiary, The Bancorp Bank, N.A. (collectively, the "Company" or "The Bancorp"), appointed Dwayne Allen to the Company's Board of Directors, effective January 1, 2025. The addition of Allen will help drive the ongoing growth of The Bancorp. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250121725354/en/Dwayne Allen Appointed to The Bancorp Board of Directors (Photo: Business Wire) Allen brings more than 25 years of senior leadership experience in technology and digital transformation, spanning a variety of global industries. Since 2021, he has served as Senior Vice President and Chi

      1/21/25 4:06:00 PM ET
      $TBBK
      Major Banks
      Finance
    • The Bancorp Announces Todd Brockman to Join Its Board of Directors

      Retired Visa Inc. Executive Set to Join The Bancorp Board of Directors in October The Bancorp, Inc. (NASDAQ:TBBK) and its wholly-owned subsidiary The Bancorp Bank, N.A. (collectively, the "Company" or "The Bancorp") are pleased to announce that Todd Brockman will join the Company's Board of Directors, effective October 1, 2024. The addition of Brockman will support the continued growth of the Company's Fintech Solutions business. Brockman brings over 25 years of experience as a senior executive in the payments and financial technology industry. He served as Senior Vice President, General Manager of Visa DPS, one of the largest issuer processors in the world. In 2021, Brockman was elevat

      8/28/24 4:01:00 PM ET
      $TBBK
      Major Banks
      Finance
    • Breakthrough T1D Proudly Announces the Appointment of New Global Mission Board Chair

      Matthew Cohn of Philadelphia will head the non-profit's volunteer-led Global Mission Board which focuses on special initiatives in type 1 diabetes research, fundraising, community engagement, and advocacy NEW YORK, July 10, 2024 /PRNewswire/ -- Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, today announced the appointment of Matthew Cohn as the new chair of the non-profit's Global Mission Board. Breakthrough T1D's Global Mission Board is a volunteer-led group, appointed by the organization's board of directors, that focuses on special initiatives in type 1 diabetes research, fundraising, community engagement and advocacy. Matthew

      7/10/24 9:00:00 AM ET
      $NBBK
      $TBBK
      Banks
      Finance
      Major Banks

    $TBBK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Brockman Todd J. bought $228,847 worth of shares (3,700 units at $61.85), increasing direct ownership by 82% to 8,217 units (SEC Form 4)

      4 - Bancorp, Inc. (0001295401) (Issuer)

      2/10/25 4:02:33 PM ET
      $TBBK
      Major Banks
      Finance
    • Director Brockman Todd J. bought $225,574 worth of shares (4,517 units at $49.94) (SEC Form 4)

      4 - Bancorp, Inc. (0001295401) (Issuer)

      10/30/24 4:02:02 PM ET
      $TBBK
      Major Banks
      Finance
    • Director Tryniski Mark E bought $251,803 worth of shares (5,000 units at $50.36), increasing direct ownership by 98% to 10,105 units (SEC Form 4)

      4 - Bancorp, Inc. (0001295401) (Issuer)

      10/30/24 4:01:37 PM ET
      $TBBK
      Major Banks
      Finance

    $TBBK
    SEC Filings

    See more
    • SEC Form SCHEDULE 13G filed by The Bancorp Inc

      SCHEDULE 13G - Bancorp, Inc. (0001295401) (Subject)

      5/15/25 11:43:55 AM ET
      $TBBK
      Major Banks
      Finance
    • SEC Form SCHEDULE 13G filed by The Bancorp Inc

      SCHEDULE 13G - Bancorp, Inc. (0001295401) (Subject)

      5/9/25 1:44:55 PM ET
      $TBBK
      Major Banks
      Finance
    • SEC Form 10-Q filed by The Bancorp Inc

      10-Q - Bancorp, Inc. (0001295401) (Filer)

      5/8/25 4:52:13 PM ET
      $TBBK
      Major Banks
      Finance

    $TBBK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP and CIO Wallace Matthew J was granted 14,107 shares and covered exercise/tax liability with 7,714 shares, increasing direct ownership by 9% to 81,191 units (SEC Form 4)

      4 - Bancorp, Inc. (0001295401) (Issuer)

      2/21/25 4:01:08 PM ET
      $TBBK
      Major Banks
      Finance
    • EVP Head of Commercial Lending Nager Jeffrey A sold $601,665 worth of shares (10,000 units at $60.17), decreasing direct ownership by 9% to 98,274 units (SEC Form 4)

      4 - Bancorp, Inc. (0001295401) (Issuer)

      2/19/25 5:14:33 PM ET
      $TBBK
      Major Banks
      Finance
    • EVP and CIO Wallace Matthew J was granted 14,107 shares and covered exercise/tax liability with 7,714 shares, increasing direct ownership by 9% to 81,191 units (SEC Form 4)

      4 - Bancorp, Inc. (0001295401) (Issuer)

      2/12/25 4:07:10 PM ET
      $TBBK
      Major Banks
      Finance

    $TBBK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by The Bancorp Inc

      SC 13G - Bancorp, Inc. (0001295401) (Subject)

      10/16/24 12:09:13 PM ET
      $TBBK
      Major Banks
      Finance
    • SEC Form SC 13G/A filed by The Bancorp Inc (Amendment)

      SC 13G/A - Bancorp, Inc. (0001295401) (Subject)

      2/13/24 5:00:45 PM ET
      $TBBK
      Major Banks
      Finance
    • SEC Form SC 13G/A filed by The Bancorp Inc (Amendment)

      SC 13G/A - Bancorp, Inc. (0001295401) (Subject)

      2/9/24 8:35:54 AM ET
      $TBBK
      Major Banks
      Finance

    $TBBK
    Financials

    Live finance-specific insights

    See more
    • The Bancorp, Inc. Reports First Quarter Financial Results

      The Bancorp, Inc. ("The Bancorp" or the "Company" or "we" or "our") (NASDAQ:TBBK), a financial holding company, today reported its financial results for the first quarter of 2025. Highlights The Bancorp reported net income of $57.2 million, or $1.19 per diluted share ("EPS"), for the quarter ended March 31, 2025, compared to net income of $56.4 million, or $1.06 per diluted share, for the quarter ended March 31, 2024, or an EPS increase of 12%. While net income increased 1% between these periods, outstanding shares were reduced as a result of increased repurchases that occurred during 2024. Return on assets and return on equity for the quarter ended March 31, 2025, amounted to 2.5% an

      4/24/25 4:50:00 PM ET
      $TBBK
      Major Banks
      Finance
    • The Bancorp, Inc. Sets First Quarter 2025 Financial Results Release Date and Conference Call

      The Bancorp, Inc. ("Bancorp") (NASDAQ:TBBK) today announced that it will release its first quarter 2025 financial results after market hours on Thursday, April 24, 2025, and invites investors and other interested parties to listen to its earnings results conference call on Friday, April 25, 2025, at 8:00 a.m. Eastern time. All interested parties can access the live conference call webcast by visiting The Bancorp site at www.thebancorp.com and clicking on the webcast link located on the home page or by dialing 1.800.549.8228 (conference ID 80395). For those who are not available to listen to the live broadcast, the replay will be available following the live call via webcast on Bancorp's we

      4/11/25 8:30:00 AM ET
      $TBBK
      Major Banks
      Finance
    • The Bancorp, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 Guidance

      The Bancorp, Inc. ("The Bancorp" or the "Company" or "we" or "our") (NASDAQ:TBBK), a financial holding company, today reported its financial results for the fourth quarter and full year of 2024. Recent Developments On December 31, 2024, the Company's wholly owned subsidiary, The Bancorp Bank, National Association (the "Bank"), closed on the sale of an $82 million real estate bridge loan ("REBL") portfolio, collateralized by apartment buildings. The sale included a $32.5 million classified loan, which was current with respect to monthly payments. The Bank provided financing to a third-party purchaser, which provided a 25% payment guaranty. The leverage and guaranty provided were consiste

      1/30/25 4:05:00 PM ET
      $TBBK
      Major Banks
      Finance